Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $8.6550 (-5.62%) ($8.5900 - $8.6550) on Thu. Mar. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.07% (three month average) | RSI | 47 | Latest Price | $8.6550(-5.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.2% a day on average for past five trading days. | Weekly Trend | CGEN declines -0.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(72%) ARKG(71%) ARKK(67%) IWO(65%) IBB(63%) | Factors Impacting CGEN price | CGEN will decline at least -2.535% in a week (0% probabilities). VIXM(-44%) VXX(-38%) UUP(-21%) IGOV(-9%) TLT(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.535% (StdDev 5.07%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $9.31 | 5 Day Moving Average | $9.02(-4.05%) | 10 Day Moving Average | $8.75(-1.09%) | 20 Day Moving Average | $9.31(-7.04%) | To recent high | -39.1% | To recent low | 13.6% | Market Cap | $716m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |